176 related articles for article (PubMed ID: 9365760)
1. Lymphoproliferative immune function in the Sydney Blood Bank Cohort, infected with natural nef/long terminal repeat mutants, and in other long-term survivors of transfusion-acquired HIV-1 infection.
Dyer WB; Geczy AF; Kent SJ; McIntyre LB; Blasdall SA; Learmont JC; Sullivan JS
AIDS; 1997 Nov; 11(13):1565-74. PubMed ID: 9365760
[TBL] [Abstract][Full Text] [Related]
2. An examination of signs of disease progression in survivors of the Sydney Blood Bank Cohort (SBBC).
Birch MR; Learmont JC; Dyer WB; Deacon NJ; Zaunders JJ; Saksena N; Cunningham AL; Mills J; Sullivan JS
J Clin Virol; 2001 Oct; 22(3):263-70. PubMed ID: 11564591
[TBL] [Abstract][Full Text] [Related]
3. Effect of long-term infection with nef-defective attenuated HIV type 1 on CD4+ and CD8+ T lymphocytes: increased CD45RO+CD4+ T lymphocytes and limited activation of CD8+ T lymphocytes.
Zaunders JJ; Geczy AF; Dyer WB; McIntyre LB; Cooley MA; Ashton LJ; Raynes-Greenow CH; Learmont J; Cooper DA; Sullivan JS
AIDS Res Hum Retroviruses; 1999 Nov; 15(17):1519-27. PubMed ID: 10580402
[TBL] [Abstract][Full Text] [Related]
4. Viral phenotypes and antibody responses in long-term survivors infected with attenuated human immunodeficiency virus type 1 containing deletions in the nef and long terminal repeat regions.
Verity EE; Zotos D; Wilson K; Chatfield C; Lawson VA; Dwyer DE; Cunningham A; Learmont J; Dyer W; Sullivan J; Churchill M; Wesselingh SL; Gabuzda D; Gorry PR; McPhee DA
J Virol; 2007 Sep; 81(17):9268-78. PubMed ID: 17567690
[TBL] [Abstract][Full Text] [Related]
5. Persistence of attenuated HIV-1 rev alleles in an epidemiologically linked cohort of long-term survivors infected with nef-deleted virus.
Churchill MJ; Chiavaroli L; Wesselingh SL; Gorry PR
Retrovirology; 2007 Jul; 4():43. PubMed ID: 17601342
[TBL] [Abstract][Full Text] [Related]
6. Phenotype and envelope gene diversity of nef-deleted HIV-1 isolated from long-term survivors infected from a single source.
Gray L; Churchill MJ; Sterjovski J; Witlox K; Learmont JC; Sullivan JS; Wesselingh SL; Gabuzda D; Cunningham AL; McPhee DA; Gorry PR
Virol J; 2007 Jul; 4():75. PubMed ID: 17634131
[TBL] [Abstract][Full Text] [Related]
7. Pathogenicity and immunogenicity of attenuated, nef-deleted HIV-1 strains in vivo.
Gorry PR; McPhee DA; Verity E; Dyer WB; Wesselingh SL; Learmont J; Sullivan JS; Roche M; Zaunders JJ; Gabuzda D; Crowe SM; Mills J; Lewin SR; Brew BJ; Cunningham AL; Churchill MJ
Retrovirology; 2007 Sep; 4():66. PubMed ID: 17888184
[TBL] [Abstract][Full Text] [Related]
8. The Sydney Blood Bank Cohort: a case-control study using a transfused HIV-1 seronegative group.
McIntyre LB; Geczy AF; Dyer WB; Learmont JC; Sullivan JS
Ann Epidemiol; 1999 Oct; 9(7):436-40. PubMed ID: 10501411
[TBL] [Abstract][Full Text] [Related]
9. Polyfunctional CD4(+) T cell responses in HIV-1-infected viral controllers compared with those in healthy recipients of an adjuvanted polyprotein HIV-1 vaccine.
Van Braeckel E; Desombere I; Clement F; Vandekerckhove L; Verhofstede C; Vogelaers D; Leroux-Roels G
Vaccine; 2013 Aug; 31(36):3739-46. PubMed ID: 23707169
[TBL] [Abstract][Full Text] [Related]
10. Differences in disease progression in a cohort of long-term non-progressors after more than 16 years of HIV-1 infection.
Rodés B; Toro C; Paxinos E; Poveda E; Martinez-Padial M; Benito JM; Jimenez V; Wrin T; Bassani S; Soriano V
AIDS; 2004 May; 18(8):1109-16. PubMed ID: 15166526
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of HIV non-progression; robust and sustained CD4+ T-cell proliferative responses to p24 antigen correlate with control of viraemia and lack of disease progression after long-term transfusion-acquired HIV-1 infection.
Dyer WB; Zaunders JJ; Yuan FF; Wang B; Learmont JC; Geczy AF; Saksena NK; McPhee DA; Gorry PR; Sullivan JS
Retrovirology; 2008 Dec; 5():112. PubMed ID: 19077215
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic vaccination with MVA-HIV-1 nef elicits Nef-specific T-helper cell responses in chronically HIV-1 infected individuals.
Cosma A; Nagaraj R; Bühler S; Hinkula J; Busch DH; Sutter G; Goebel FD; Erfle V
Vaccine; 2003 Dec; 22(1):21-9. PubMed ID: 14604567
[TBL] [Abstract][Full Text] [Related]
13. Role of human immunodeficiency virus (HIV)-specific T-cell immunity in control of dual HIV-1 and HIV-2 infection.
Zheng NN; McElrath MJ; Sow PS; Hawes SE; Diallo-Agne H; Stern JE; Li F; Mesher AL; Robinson AD; Gottlieb GS; Huang Y; Kiviat NB
J Virol; 2007 Sep; 81(17):9061-71. PubMed ID: 17582003
[TBL] [Abstract][Full Text] [Related]
14. Strong human immunodeficiency virus (HIV)-specific cytotoxic T-lymphocyte activity in Sydney Blood Bank Cohort patients infected with nef-defective HIV type 1.
Dyer WB; Ogg GS; Demoitie MA; Jin X; Geczy AF; Rowland-Jones SL; McMichael AJ; Nixon DF; Sullivan JS
J Virol; 1999 Jan; 73(1):436-43. PubMed ID: 9847349
[TBL] [Abstract][Full Text] [Related]
15. Longitudinal analysis of human immunodeficiency virus type 1 nef/long terminal repeat sequences in a cohort of long-term survivors infected from a single source.
Churchill MJ; Rhodes DI; Learmont JC; Sullivan JS; Wesselingh SL; Cooke IR; Deacon NJ; Gorry PR
J Virol; 2006 Jan; 80(2):1047-52. PubMed ID: 16379007
[TBL] [Abstract][Full Text] [Related]
16. HIV-1-specific CD8 T cell responses in a pediatric slow progressor infected as a premature neonate.
Chakraborty R; Gillespie GM; Reinis M; Rostron T; Dong T; Philpott S; Burger H; Weiser B; Peto T; Rowland-Jones SL
AIDS; 2002 Oct; 16(15):2085-7. PubMed ID: 12370511
[TBL] [Abstract][Full Text] [Related]
17. Defective nef alleles in a cohort of hemophiliacs with progressing and nonprogressing HIV-1 infection.
Brambilla A; Turchetto L; Gatti A; Bovolenta C; Veglia F; Santagostino E; Gringeri A; Clementi M; Poli G; Bagnarelli P; Vicenzi E
Virology; 1999 Jul; 259(2):349-68. PubMed ID: 10388660
[TBL] [Abstract][Full Text] [Related]
18. Presence of HIV-1 Nef specific CD4 T cell response is associated with non-progression in HIV-1 infection.
Pancré V; Delhem N; Yazdanpanah Y; Delanoye A; Delacre M; Depil S; Moralès O; Mouton Y; Auriault C
Vaccine; 2007 Aug; 25(31):5927-37. PubMed ID: 17600593
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of major histocompatibility class I on human dendritic cells by HIV Nef impairs antigen presentation to HIV-specific CD8+ T lymphocytes.
Andrieu M; Chassin D; Desoutter JF; Bouchaert I; Baillet M; Hanau D; Guillet JG; Hosmalin A
AIDS Res Hum Retroviruses; 2001 Sep; 17(14):1365-70. PubMed ID: 11602047
[TBL] [Abstract][Full Text] [Related]
20. Immunologic and virologic status after 14 to 18 years of infection with an attenuated strain of HIV-1. A report from the Sydney Blood Bank Cohort.
Learmont JC; Geczy AF; Mills J; Ashton LJ; Raynes-Greenow CH; Garsia RJ; Dyer WB; McIntyre L; Oelrichs RB; Rhodes DI; Deacon NJ; Sullivan JS
N Engl J Med; 1999 Jun; 340(22):1715-22. PubMed ID: 10352163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
